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Abstract
The highly expressed D7 protein family of mosquito saliva has previously been shown to act as an anti-inflammatory
mediator by binding host biogenic amines and cysteinyl leukotrienes (CysLTs). In this study we demonstrate that AnSt-D7L1,
a two-domain member of this group from Anopheles stephensi, retains the CysLT binding function seen in the homolog
AeD7 from Aedes aegypti but has lost the ability to bind biogenic amines. Unlike any previously characterized members of
the D7 family, AnSt-D7L1 has acquired the important function of binding thromboxane A2 (TXA2) and its analogs with high
affinity. When administered to tissue preparations, AnSt-D7L1 abrogated Leukotriene C4 (LTC4)-induced contraction of
guinea pig ileum and contraction of rat aorta by the TXA2 analog U46619. The protein also inhibited platelet aggregation
induced by both collagen and U46619 when administered to stirred platelets. The crystal structure of AnSt-D7L1 contains
two OBP-like domains and has a structure similar to AeD7. In AnSt-D7L1, the binding pocket of the C-terminal domain has
been rearranged relative to AeD7, making the protein unable to bind biogenic amines. Structures of the ligand complexes
show that CysLTs and TXA2 analogs both bind in the same hydrophobic pocket of the N-terminal domain. The TXA2 analog
U46619 is stabilized by hydrogen bonding interactions of the v-5 hydroxyl group with the phenolic hydroxyl group of Tyr
52. LTC4 and occupies a very similar position to LTE4 in the previously determined structure of its complex with AeD7. As
yet, it is not known what, if any, new function has been acquired by the rearranged C-terminal domain. This article presents,
to our knowledge, the first structural characterization of a protein from mosquito saliva that inhibits collagen mediated
platelet activation.
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Introduction
Hematophagous arthropods produce a varied mix of salivary
proteins, peptides, and small molecules aimed at overcoming the
hemostatic and inflammatory responses of the host. In order to
successfully take a meal, the blood feeder must prevent host
vasoconstrictive responses and the clotting of blood as it travels
through the mouthparts to the gut [1,2]. The inhibition of
immediate inflammatory responses is also essential, in that the
swelling, itching, and pain resulting from arthropod bites may
themselves interfere with the ingestion of blood or elicit defensive
behavioral responses from the host [1–4]. Additionally, inflam-
mation in the skin at the site of feeding has been shown to
influence the establishment of infection by arthropod-vectored
pathogens, making the anti-inflammatory components of saliva
important from this standpoint as well [5,6]. In fact, several
pathogens take advantage of the biological properties of the
salivary mixture to infect their hosts and cause disease. It has been
demonstrated that immunity against salivary components from
different mosquito species is able to reduce disease transmission by
these vectors [7–10]. In addition, the mosquito life cycle is affected
by immunization against salivary molecules [11].
Wounding as a result of a mosquito bite exposes collagen and
other matrix proteins that act to initiate the activation of platelets.
The stimulation of TXA2 biosynthesis and the release of dense
granules containing small molecule mediators of platelet activation
and inflammation such as ADP and serotonin potentiate the
activation response. In sensitized hosts, IgE antibodies recognizing
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release of large amounts of histamine and the synthesis of CysLTs
[1,2]. These compounds cause rapid swelling, pain, increases in
vascular permeability, and itching in the host. Numerous proteins
have now been identified in the salivas of blood feeders that act to
limit the responses of platelets and mast cells to arthropod bites
[12–19].
An important functional theme in the physiology of blood
feeding is the use of specific salivary binding proteins to sequester
small-molecule agonists of inflammation and platelet activation
[14,17,18,20]. Since hematophagy has evolved independently
many times in insects and other arthropods, proteins from
different structural families act to perform these functions in the
various blood-feeding species [1,2,13]. To generate the molecular
diversity needed to bind small molecule effectors of widely varying
structure, multigene families have arisen from gene duplication
events, with the resulting gene products being expressed
specifically in the salivary glands of blood feeders [21]. Individual
members of these families have diverged in sequence and
structure, resulting in an array of protein forms with different
ligand binding specificities. In some instances, salivary proteins
have acquired the ability to form specific interactions with host
proteins while maintaining the ability to bind small molecule
effectors. The diversity of these binding protein families may
reflect an evolutionary arms race between the arthropod blood
feeders and the sophisticated hemostatic, inflammatory, and
immune systems of their vertebrate hosts.
Two protein families have thus far been implicated as
scavengers of small molecule modulators of inflammation and
platelet aggregation in blood feeding arthropods. The lipocalins
serve this function in ticks and triatomine bugs, while members of
the D7 family serve the function in mosquitoes [14,20,22]. D7
proteins are structurally related to the arthropod OBPs and come
in two forms. The long form proteins, as exemplified by AeD7
from the saliva of Aedes aegypti, have two OBP domains, with each
domain binding a single ligand molecule [14–16]. Single-domain
D7 proteins are found in mosquitoes and other members of the
Nematocera suborder of flies, with those from An. gambiae (referred
to as D7r proteins) being extensively characterized and found to
bind a single ligand molecule per protein [14]. A group of proteins
orthologous to D7r is found in An. stephensi, and one of these has
also been found to function as an inhibitor of coagulation and
inflammation pathways by binding factor XII(a) and high
molecular weight kininogen [23]. The functionally equivalent
ortholog of this molecule has been identified in An. gambiae as the
protein D7r1 [14]. Both AeD7 and the D7r proteins bind the
biogenic amines serotonin, norepinephrine, and histamine with
high affinity. The C-terminal domain of AeD7 is responsible for
biogenic amine binding and is homologous to the single domain
D7r proteins, while the N-terminal domain is distinct in sequence
and structure and is a scavenger of CysLTs [15]. Despite the
presence of the highly expressed, biogenic amine-binding, short
form D7 proteins in all species of Anopheles examined, the two-
domain long forms of D7 have not been lost, suggesting that they
may play, at least in part, a different role in these species.
In this study we examine the ligand binding specificity,
physiological function, and three dimensional structure of AnSt-
D7L1, a two-domain D7 protein from An. stephensi, a vector of the
malaria parasite. We found that unlike other members of the D7
family, this protein functions as a TXA2-binding protein, thereby
acting to inhibit the activation of platelets during feeding. We also
describe the crystal structures of ligand complexes that provide, to
our knowledge, the first view of the molecular interactions
involved in TXA2 binding. We ask whether evolution of the short
D7 proteins in Anopheles sp. and their assumption of the biogenic
amine binding function otherwise seen in the long form of Aedes
has resulted in the evolution of functional changes in the protein.
We find that AnSt-D7L1 has acquired the ability to bind the
vasoactive platelet aggregation and proinflammatory agonist
TXA2 in addition to maintaining the ability to bind CysLTs.
Additionally, the C-terminal domain has undergone extensive
structural rearrangements resulting in a loss of the biogenic amine
binding function.
Results
AnSt-D7L1 a Two-Domain D7 Protein
The amino acid sequence of AnSt-D7L1 is 31% identical to that
of AeD7, the two-domain D7 from Ae. aegypti (Figure 1). AeD7
contains binding sites for both CysLTs and biogenic amines, with
the CysLT binding site lying in the N-terminal domain and the
biogenic amine binding site in the C-terminal domain. Residues
lining the CysLT binding pocket in the N-terminal domain of
AeD7 are conserved to a large degree in AnSt-D7L1 and other
two-domain D7 proteins from Anopheles sp. (Figure 1). The C-
terminal domain of AnSt-D7L1 also shows conservation of most
but not all of the residues from the biogenic amine binding pocket
in AeD7 and the D7r proteins from Anopheles species. Notably, the
position of His 189 in AeD7 contains alanine (Ala 190) in AnSt-
D7L1 and other two-domain D7 proteins from Anopheles species
(Figure 1). This residue is highly conserved in biogenic amine-
binding D7 proteins where it forms a hydrogen bond with the
phenolic hydroxyl groups of serotonin and catecholamines
[15,16].
AnSt-D7L1 Binds CysLTs
In order to determine the role of AnSt-D7L1 in blood feeding,
we examined its ligand binding properties. A series of ITC
experiments were performed to screen potential candidate ligands,
including bioactive lipids, biogenic amines, and nucleotides that
are known to be involved in inflammation and hemostasis
(Figure S1).
AnSt-D7L1 bound the CysLTs LTC4, LTD4, and LTE4 with a
stoichiometry of one ligand molecule per molecule of protein
Author Summary
When feeding, a female mosquito must inhibit the blood
clotting and inflammatory responses of the host. To do
this, the insect produces salivary proteins that neutralize
key host molecules participating in clotting and inflam-
mation. Here, we describe a salivary protein AnSt-D7L1
that scavenges both thomboxane A2 and cysteinyl
leukotrienes, two substances involved in blood vessel
constriction, platelet aggregation, and inflammatory re-
sponses to an insect bite. We produced this protein in
bacteria and showed that it tightly binds both these
molecules, inhibiting the processes in which they are
involved. We then determined its structure using X-ray
crystallography and showed that there is a single binding
site in one domain of the protein, accommodating both
thromboxane A2 and cysteinyl leukotrienes, and that this
site is responsible for the scavenging effect of the protein.
These studies reveal the structural features of proteins
needed to bind to key molecules of potential pharmaco-
logical importance and add to our understanding of the
process of mosquito blood feeding, which is essential for
transmission of the malaria parasite.
Structure of a Mosquito Eicosanoid-Binding Protein
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mately 10 times higher than those previously reported for the
related protein AeD7 [15]. As in AeD7, the affinities for the three
CysLTs are similar to one another, suggesting that the protein
recognizes the lipid portion of the ligand, rather than the peptide
portion. AnSt-D7L1 did not bind LTB4, a ligand previously shown
to bind with AeD7 [15] with low affinity (unpublished data).
AnSt-D7 L1 Binds Thromboxane A2 Analogs
The eicosanoid TXA2 is an important mediator of platelet
activation and vascular tone. Because of its instability, TXA2
binding could not be evaluated directly using ITC. In solution, it
undergoes rapid hydrolysis to form TXB2, a stable but
physiologically inactive compound. Binding with stable analogs
could be measured, however, with U46619 and carbocyclic TXA2
exhibiting dissociation constants of approximately 98 nM and
38 nM, respectively (Figure 2D,E). This suggested that TXA2 itself
may be a physiological target of AnSt-D7L1. The binding affinity
for TXB2, the major hydrolysis product of TXA2, was approx-
imately 13-fold lower than for U46619, demonstrating that the
protein may be able to discriminate between the active and
inactive thromboxane forms in vivo (Figure 2D,F).
AnSt-D7L1 Does Not Bind Biogenic Amines, ADP, or PAF
AeD7 and the single-domain D7r proteins of An. gambiae have
been characterized as scavengers of the biogenic amines serotonin,
norepinephrine, and histamine [14–16]. AnSt-D7L1 showed no
detectable binding of biogenic amines, however, suggesting that its
C-terminal domain is structurally distinct from the comparable,
biogenic amine-binding C-terminal domain of AeD7 (unpublished
data). We have also tested the binding of AnSt-D7L1 to the
platelet activating phospholipid derivative PAF and also to the
nucleotide ADP. Neither showed any detectable binding (unpub-
lished data).
AnSt-D7L1 Shows Weak Binding with Prostaglandins and
Does Not Bind Arachidonic Acid
To determine if AnSt-D7L1 is specific in its binding for CysLTs
and TXA2, we screened a number of additional eicosanoid
compounds using ITC. AnSt-D7L1 showed no detectable binding
to AA (unpublished data) but bound the prostaglandins PGD2,
PGE2, and PGF2a with affinities much lower than those seen with
CysLTs and TXA2 analogs (Figure 3). The PGH2 analog U51605
also showed detectable but much weaker binding than U46619
(Figure 3D). This compound is also similar in structure to U46619
and carbocyclic TXA2 but lacks the hydroxyl group at the v-5
position of the hydrocarbon chain, suggesting that this moiety
plays an important role in the binding of TXA2 analogs.
AnSt-D7L1 Binding to LTC4 Does Not Modify Bound
CysLTs
To test for a hydrolytic or enzymatic function of AnSt-D7L1,
LTC4 was incubated with the protein at 25uC and the mixture was
analyzed by HPLC and mass spectrometry. Analytical gel
filtration chromatography revealed only one peak corresponding
in molecular size to the protein, indicating the formation of a
leukotriene complex (Figure S2). Fractions containing the complex
were then applied to a C18 HPLC column, eluted with methanol,
and analyzed by mass spectrometry. The spectrum of the bound
ligand was essentially identical to that of the free ligand, indicating
that the protein binds but does not chemically modify LTC4
(Figure S3).
Figure 1. Amino acid sequence alignment of D7 proteins from Anopheles sp. and Ae. aegypti. The alignment shows sequences of the two-
domain D7 forms from An. stephensi (AnSt-D7L1), An. gambiae, An. funestus, and An. darlingi in comparison to the two-domain protein from Aedes
aegypti (AeD7). Also shown are the four single-domain D7 proteins (D7r1–4) from An. gambiae. Conserved residues contained in the ligand binding
pocket of the N-terminal domain are highlighted in green, while those in the biogenic amine binding pocket of AeD7 and Anopheles single-domain
D7s are highlighted in yellow. In the single-domain proteins and in the C-terminal domain of the two-domain proteins the conserved histidine
residue (His 189 of AeD7) involved in biogenic amine binding is marked with an asterisk. Also highlighted in magenta is Trp 173 of AnSt-D7L1. In
biogenic amine-binding forms, this residue is either leucine or valine.
doi:10.1371/journal.pbio.1000547.g001
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Contraction
One of the well-characterized physiological effects of CysLTs
and TXA2 is the induction of smooth muscle contraction [24],
including pulmonary vascular smooth muscle [25], guinea pig
ileum [26], and aorta [27]. AnSt-D7L1 effectively abrogated
LTC4-induced contraction (Figure 4A) of ileum preparations,
demonstrating the ability of the protein to sequester ligand
molecules and prevent them from interacting with their cognate
receptors. When administered to a preparation of rabbit aorta,
AnSt-D7L1 also inhibited U46619-induced contraction, increas-
ing by approximately 3-fold the amount of U46619 needed to
promote contraction in the absence of the protein (Figure 4B).
AnSt-D7L1 was also able to reverse contraction induced by
U46619 when added after the agonist (Figure 4C). In order to
verify that the protein had no additional effect on the integrity of
aorta preparations, phenylephrine (PE), an a1-adrenergic receptor
agonist, was added to the preparation after relaxation by AnSt-
D7L1. The aorta contracted normally, further verifying that the
effect of AnSt-D7L1 was due only to its ability to bind U46619
(Figure 4C).
AnSt-D7L1 Inhibits Collagen-Induced Platelet
Aggregation
Exposure of collagen from the subendothelial matrix at the site
of a wound plays a key role in triggering platelet adhesion and
Figure 2. Binding of CysLTs and TXA2 analogs by ITC. Binding experiments were performed on a MicroCal VP-ITC instrument. For CysLT
experiments the syringe contained a 20 mM ligand solution, and the AnSt-D7L1 concentration in the cell was 2 mM. For the TXA2 analog experiments
the ligand solution used to fill the syringe was 40 mM and the AnSt-D7L1 concentration in the cell was 4 mM. Assays were performed at 35uC with
successive 10 mL injections. The upper curve in each panel shows the measured heats for each injection, while the lower plot shows the enthalpies for
each injection along with the fit to a single binding site model used to estimate the dissociation constant (Kd), enthalpy of binding (DH), entropy of
binding (TDS), and the binding stoichiometry (N). Panels: (A) LTC4, (B) LTD4, (C) LTE4, (D) U46619, (E) carbocyclic TXA2, (F) TXB2.
doi:10.1371/journal.pbio.1000547.g002
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to binding of the VWF-collagen complex with glycoprotein Ib-IX-
V (GPIb-IX-V) or aIIbb3, or direct, via interaction with the platelet
collagen receptors a2b1 (or glycoprotein Ia/IIa) and glypoprotein
VI (GPVI) [28–32]. These events lead to the synthesis of TXA2
and release of ADP, which act together with collagen to amplify
pro-aggregatory signals resulting in ‘‘inside out’’ activation of
integrin aIIbb3, the receptor for fibrinogen and fibrin, and
consequent platelet aggregation [29,32]. At higher concentrations,
collagen acts as a strong agonist of GPVI leading to platelet
activation and aggregation in a manner that is independent of
secretion of TXA2 or ADP [31,32]. At low concentrations of
collagen, however, aggregation depends on amplification of the
response by TXA2 and ADP [31].This being the case, we
hypothesized that binding of TXA2 by AnSt-D7L1 should inhibit
platelet activation by low concentrations of collagen and have no
effect at higher collagen concentrations.
When we incubated stirred platelets with AnSt-D7L1 and
stimulated with a low concentration (1.6 mg/mL) of collagen, we
observed a delay in the onset of shape change and a diminished
extent of platelet aggregation (Figure 5A). The degree of inhibition
was dependent on the concentration of AnSt-D7L1, and under
these conditions, aggregation was almost completely inhibited by a
concentration of 1 mM AnSt-D7L1 (Figure 5A). Conversely, when
platelets were stimulated by collagen at high concentration
(Figure 5B) or by the potent GPVI agonist convulxin (Figure 5C),
the inhibitory effect of AnSt-D7L1 was lost.
Platelet aggregation induced by collagen is also affected by
apyrase, indicating an important role for ADP. Shape change
induced by lower concentrations of ADP is a TXA2-independent
process, however, and should not be limited by an inhibitor
targeting TXA2 [33]. When we administered the minimal dose of
ADP needed to elicit shape change to stirred platelets, preincu-
bation with AnSt-D7L1 had no inhibitory effect (Figure 5D). This
indicates that AnSt-D7L1 does not affect ADP signaling directly.
Conversely, RPAI1, a specific ADP-binding protein from Rhodnius
prolixus saliva [22,34], was able to completely inhibit the shape
change response under these conditions (Figure 5D). AnSt-D7L1
also showed no effect on platelet aggregation induced by the
protein kinase C activator PMA (Figure 5E) or on ristocetin-
Figure 3. Binding of AnSt-D7L1 to prostaglandins and prostaglandins analogues by ITC. Binding experiments were performed on a
MicroCal VP-ITC instrument. For these experiments, the ligand solution used to fill the syringe was 80 mM and AnSt-D7L1 concentration in the
calorimeter cell was 8 mM. Assays were performed at 35uC with successive 10 mL injections. Upper curve in each panel shows the heat for each
injection; lower part shows the enthalpies for each injection and data were fit to a single binding site model used to calculate the binding
stoichiometry (N), dissociation constant (Kd), enthalpy of binding (DH), and entropy of binding (TDS). Panels: (A) PGD2, (B) PGE2, (C) PGF2a, (D)
U51605.
doi:10.1371/journal.pbio.1000547.g003
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(Figure 5F). Both of these pathways are independent of TXA2,
suggesting that the inhibition of collagen-mediated aggregation by
AnSt-D7L1 depends only on its ability to bind TXA2.
AnSt-D7L1 Mimics the Effects of TXA2 Receptor
Antagonists or Inhibitors of Biosynthesis
When platelets were activated by collagen in the presence of SQ
29,548, an antagonist of TXA2 receptor (TP), or were pre-treated
with indomethacin, an inhibitor that prevents TXA2 biosynthesis,
aggregation was attenuated (Figure 6A). The effect obtained with
both treatments was very similar to that seen with 3 mM AnSt-
D7L1 (Figure 6A), further supporting the idea that the activity of
the protein is due to its ability to bind TXA2. This result is
important in showing that AnSt-D7L1 is able to bind TXA2 itself,
since in ITC experiments we were limited to the testing of stable
analogues of TXA2.
AnSt-D7L1 Inhibits Activation of Platelets by TXA2
Analogs and Biosynthetic Precursors
AnSt-D7L1 inhibited U46619 (1.3 mM)-induced platelet aggre-
gation in a concentration-dependent manner (Figure 6B). At low
concentrations of AnSt-D7L1 (less than a 1:1 ratio of protein to
inhibitor), the protein delayed but did not prevent platelet
aggregation. As the ratio approached 1:1 (at 1 mM AnSt-D7L1),
the protein dramatically inhibited aggregation, an observation
consistent with the 1:1 binding stoichiometry seen in ITC
experiments (Figure 2D).
Although higher concentrations (2 and 3 mM) of the protein
completely prevented aggregation of platelets, shape change was
not completely inhibited and could only be prevented by blockade
of the TP receptor with the antagonist SQ 29,548 (Figure 6B).
This is possibly due to the fact that TP-mediated shape change is
coupled to a Ga12/13 protein signaling cascade, which requires
only small amounts of U46619 (EC50 around 13 nM) [27,35].
Larger amounts of U46619 are necessary to promote aggregation,
which is dependent on Gaq/11-coupled signaling [27,35].
Since AA is a biosynthetic precursor of TXA2, as well as of
prostaglandins, we tested the effect of AnSt-D7L1 on platelet
aggregation induced by this compound. AnSt-D7L1 drastically
decreased platelet aggregation induced by AA, showing a similar
effect to that observed when platelets were pre-treated with
indomethacin (Figure 6C). Since ITC data indicated that this
protein does not bind AA itself (unpublished data), we conclude
that the observed effect is due to AnSt-D7L1 binding of newly
synthesized TXA2.
Crystal Structures of AnSt-D7L1: Ligand-Free Protein
In order to characterize the ligand binding sites and understand
the relationships and evolution of proteins in the D7 family, we
determined the crystal structure of AnSt-D7L1 in the absence of
ligands and in the presence of U46619 and LTC4 (Table 1). The
ligand-free form of the protein crystallized in the space group
P212121 with one protein molecule in the asymmetric unit. The
structure revealed two OBP domains with the N-terminal domain
containing three disulfide bonds and the C-terminal domain
Figure 4. Smooth muscle contraction bioassay. (A) Guinea pig
ileum samples were pre-incubated with buffer (solid line) or 1 mM AnSt-
D7L1 (dotted line) and contraction was induced by 0.1 mM LTC4 (L), as
indicated by the far left hand arrow, in both control and experimental
preparations. Since in the presence of AnSt-D7L1 no contraction was
observed after first LTC4 addition, further successive additions of 0.1 mM
LTC4 were made only to this preparation (dotted line), as indicated by
additional arrows. (B) Rat aorta samples were pre-incubated with buffer
(solid line) or AnSt-D7L1 (dotted line) and the effect of addition of
0.1 mM U46619 (U) was recorded. Since there was no contraction in the
presence of the AnSt-D7L1 after the first addition, further additions of
0.1 mM U46619 were made only to the preparation incubated with
protein, as indicated by additional arrows. (C) The ability of AnSt-D7L1
to reverse contraction induced by U46619 was tested by pre-contacting
rat aorta samples with 1 mM U46619 (as indicated by the letter ‘‘U’’).
After the plateau was achieved, in the experimental sample (dotted
line) 0.1 mM of AnSt-D7L1 was added (indicated by D7 in the figure),
which caused relaxation of the sample. In order to show that the muscle
was still functional, 3 mM phenylephrine was added (indicated by PE). A
control (solid line) experiment was performed without addition of
protein or PE in order to show that in the absence of AnSt-D7L1
contraction lasts throughout the experiment.
doi:10.1371/journal.pbio.1000547.g004
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contains a number of residues that interact by hydrogen bonding
or cation pi interactions. In its overall structure, the protein is
similar to AeD7 with an RMS deviation of 1.82 A ˚ over 239 Ca
positions (Figures 1, 7).
The N-terminal domain of AnSt-D7L1 consists of seven a-
helices oriented around a solvent-accessible hydrophobic channel
(Figure 7A,B). Superposition of the N-terminal domains of AeD7
and AnSt-D7L1 shows the two to be quite similar in structure,
with an RMS positional deviation for 144 Ca positions of 1.36 A ˚
(Figure S4). Like AeD7, the apparent entry point to the ligand-
binding channel is surrounded by a positively charged electrostatic
surface that would be attractive to the anionic eicosanoid ligands
(Figure 8D) [15].
In AnSt-D7L1 the C-terminal domain also contains seven a-
helices and is less similar in overall structure to AeD7 than is the
N-terminal domain (Figures 7A,B and S4). The C-terminal
domain of AeD7 is made up of seven a-helices in the ligand-free
form and an eighth helix (H2) forms in response to the binding of
norepinephrine (Figure 7C,D) [15]. This helix corresponds to the
seventh a-helix (H2) of AnSt-D7L1 (Figure 7A–D) [15]. In AnSt-
D7L1, the second a-helix of AeD7 (B2) is not present
(Figure 7A,B). Rather, this region forms a predominantly coil
structure extending between Lys 169 and Ser 184 containing a b-
turn between residues Trp 173 and Gly 176. This portion of the
C-terminal domain also lacks a cysteine residue found in AeD7
(Cys 173) and other D7 proteins, which forms a disulfide bond
with a second cysteine (Cys 301 in AeD7) located at or near the C-
terminal end of the protein (Figure 7C,D) [15,16]. As a result of
these changes, the terminal a-helix of the C-terminal domain (H2)
is positioned differently than the corresponding a-helix H2 in
AeD7.
Many of the residues forming the C-terminal domain ligand
binding pocket in AeD7 are conserved in AnSt-D7L1, but some
occupy different positions, giving a completely different architec-
ture to the structure of the region. Arg 177 in AnSt-D7L1 is
equivalent to Arg 176 in AeD7 but is positioned such that its side
chain partially occupies the same space as the ligand in the AeD7-
Figure 5. Effect of AnSt-D7L1 on platelet aggregation promoted by different agonists. Platelet-rich human plasma was incubated with
different concentrations of AnSt-D7L1 for 1 min prior to the addition of agonists as indicated. Aggregation was measured at 37uCo na n
aggregometer. Unless otherwise stated protein concentration (mM) is shown under respective curves. (A) Concentration dependence of AnSt-D7L1
inhibition of collagen-mediated platelet aggregation at low concentration of collagen. (B) Lack of inhibition of collagen-mediated platelet
aggregation by AnSt-D7L1 at high concentration of collagen. (C) Lack of inhibition of convulxin-mediated platelet aggregation by AnSt-D7L1. (D)
ADP-mediated platelet aggregation in the absence of any protein (control), in the presence of 3 mM AnSt-D7L1, or in the presence of 3 mM RPAI1,
which is known to bind ADP. (E) Lack of effect of AnSt-D7L1 on PMA-induced platelet aggregation. (F) Lack of effect of AnSt-D7L1 on ristocetin-
induced platelet aggregation.
doi:10.1371/journal.pbio.1000547.g005
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including the presence of tryptophan rather than leucine at
position 173 in AnSt-D7L1, this modification acts to further fill the
space equivalent to the biogenic amine binding pocket of the
AeD7 C-terminal domain (Figure 9A,B). Although the identities of
most of the residues forming hydrogen bonds with biogenic amines
in AeD7 are conserved in AnSt-D7L1, some changes are
apparent. Most notably, a histidine residue (position 189 in
AeD7) that forms hydrogen bonds with the phenolic hydroxyl
groups of serotonin and norepinephine is mutated to alanine (Ala
190) in AnSt-D7L1 (Figure 9A,B). These positional rearrange-
ments and amino acid substitutions clearly explain the loss of the
biogenic amine binding function in AnSt-D7L1 and indicate that
the C-terminal domain in AnSt-D7L1 performs a different
function than its counterpart AeD7. This novel function has not
yet been identified.
Ligand Complexes of AnSt-D7L1: Details of the
N-Terminal Ligand Binding Pocket
Anst-D7L1 was crystallized in the presence of a 1.3-fold molar
excess of either U46619 or LTC4 using otherwise identical
crystallization conditions as for the ligand-free form. Both ligand
complexes crystallized in the space group P21 rather than P212121,
with a single protein molecule in the asymmetric unit. Rather than
binding in the separate domains of AnSt-D7L1, both ligands were
found to bind in the hydrophobic pocket of the N-terminal domain
of the protein.
The structure of the U46619 complex showed excellent electron
density for the ligand, allowing a complete analysis of its binding
interactions (Figure 8A,B). U46619 is bound with the unmodified
end of the hydrocarbon chain projecting into the hydrophobic
pocket, while the carboxyl group is positioned near the surface of
the protein (Figure 8A). The hydroxyl group at the v-5 position of
the hydrocarbon chain of the ligand is stabilized by hydrogen
bonds with the phenolic hydroxyl of Tyr 52 and the carbonyl
oxygen of Trp 37, while the oxygen atom contained in the bicyclic
ring system participates in a hydrogen bonding network with the
carbonyl oxygen of Leu 13 via an intervening water molecule
(Figure 8A). The carboxyl group of the ligand forms hydrogen
bonds with the side chain of Lys 152, as well as with an ordered
water molecule near the entry to the ligand binding channel, while
the v-end of the fatty acid chain sits in a hydrophobic pocket
formed in part by the side chains of Leu 42, Val 56, and Leu 57
(Figure 8A).
The LTC4 complex of AnSt-D7L1 is similar in structure to the
LTE4 complex of AeD7 with the ligand being bound at essentially
the same site as U46619 (Figure 8C). The quality of the electron
density for LTC4 was somewhat lower than for U46619, probably
reflecting the relative instability of the ligand over the 2–3-week
crystallization period. Nevertheless, the fatty acid portion of the
molecule could be positioned in the ligand binding channel
(Figure 8C). The peptide portion of LTC4 was not well ordered,
consistent with the fact that similar thermodynamic parameters for
the three CysLTs were observed in ITC experiments. The
carboxyl group of the ligand is positioned similarly to U46619
and also forms a hydrogen bond or salt bridge with the side chain
of Lys 152 (Figure 8C). The longer unsaturated hydrocarbon chain
of LTC4 projects further into the ligand binding channel than does
that of U46619. Near the position occupied by the v-methyl group
of U46619, the hydrocarbon chain of LTC4 is bent approximately
90u and the terminal four carbon atoms are accommodated in a
hydrophobic cavity lined by the side chains of Tyr 117, Ile 62, Leu
60, Trp 40, and Leu 57 (Figure 8C).
The structure of the C-terminal domain in the ligand complexes
is quite similar to the ligand-free protein and shows no evidence of
interaction with either U46619 or LTC4. The position of helix H2
and the structure of the region corresponding to helix B2 in AeD7
are nearly identical to those seen in the ligand-free form of the
protein. This again demonstrates that these differences between
AnSt-D7L1 and AeD7 are not the result of crystal packing
interactions. However, the region to the C-terminal side of helix
H2 takes on a different conformation in the ligand complexes than
in the ligand-free protein. In the absence of ligands, the segment
between Leu 291 and the C-terminus (Phe 297) extends away from
the surface of the protein and forms a b-turn between Thr 293 and
His 296. In the ligand complexes the segment between Leu 291
and Val 295 packs against the surface of the protein, where it
participates in a number of intramolecular hydrogen bonds (Figure
S4). It is not clear whether the change in the C-terminal
conformation is attributable to crystal packing differences or is a
Figure 6. AnSt-D7L1 affects platelet aggregation promoted by
TXA2. Platelet-rich human plasma was incubated with different
concentrations of AnSt-D7L1 or buffer, as indicated, for 1 min prior to
the addition of agonists indicated in each panel. (A) Aggregation
mediated by collagen in the presence of TXA2 antagonists. The effect of
3 mM AnSt-D7L1 on collagen-induced aggregation was similar to the
effect promoted by a thromboxane receptor (TP) antagonist (SQ 29,548)
or by pre-incubating platelets with indomethacin, a general cycloox-
ygenase inhibitor. The curve marked control shows the normal
response of platelets to collagen. (B) AnSt-D7L1 has a dose dependent
effect on U46619-induced platelet aggregation. Protein concentrations
are shown on the bottom of each curve. The last curve in the panel
shows the effect of 1 mM SQ 29,548 in the absence of AnSt-D7L1. (C)
AnSt-D7L1 (3 mM) affects AA-induced platelet aggregation. A similar
effect is observed when platelets are pre-incubated with indomethacin
in the absence of protein, inhibiting TXA2 production. Respective
treatments are indicated in the bottom of each curve.
doi:10.1371/journal.pbio.1000547.g006
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binding pocket.
Discussion
Prevention of host hemostasis and inflammation is the primary
function of the salivary secretion of blood feeding arthropods
[2–4]. Toward this end an extremely diverse group of salivary
proteins and peptides have evolved to inhibit key processes in these
systems. Salivary protein genes tend to be highly duplicated and
arranged in clusters. Often, individual members of these clusters
have diverged in sequence and added new functions important for
blood feeding. The duplication and divergence paradigm is well
illustrated by the D7 salivary protein family in hematophagous
Diptera, with members of this group playing numerous important
roles in blood feeding. Isawa and co-workers described a single-
domain D7 protein from An. stephensi, referred to as hamadarin,
and found it to bind coagulation factor XII and high molecular
weight kininogen [23]. This protein acts both to inhibit the contact
pathway of coagulation and the generation of the proinflammatory
peptide bradykinin. In An. gambiae, single-domain D7 proteins
(D7r1, D7r2, D7r3, and D7r4) as well as the C-terminal domain of
the two-domain D7 present in Ae. aegypti (AeD7) inhibit
inflammation and vascular tone by binding biogenic amines
[14]. One of these, D7r1, is an ortholog of hamadarin and has
been shown to inhibit coagulation [14]. Calvo et al. [15] found
that the N-terminal domain of AeD7 bound CysLTs, a group of
proinflammatory lipid mediators, while the C-terminal domain
bound biogenic amines in a manner similar to the single domain
proteins. Here we have shown that the two-domain D7 protein
from An. stephensi, AnSt-D7L1, binds CysLTs like AeD7 but also
functions as an inhibitor of platelet activation by binding TXA2.
AeD7 showed no detectable binding with the TXA2 analog
U46619, while AnSt-D7L1 binds this ligand with high affinity.
Additionally, the C-terminal domain has lost the ability to bind
biogenic amines, a function found in apparent orthologs of this
protein in culicine mosquitoes.
The N-Terminal Domain and Eicosanoid Binding
The binding site for eicosanoid ligands lies in a pocket in the N-
terminal domain of AnSt-D7L1, which is lined with mostly
hydrophobic residues that accommodate a large portion of the
fatty acid chain. CysLTs are substituted at the v-14 position of the
chain while TXA2 and its analogs contain a hydroxyl group at the
v-5 position (Figure S1). Binding of TXA2 analogs by AnSt-D7L1
appears to result from its ability to accommodate this substitution
pattern. AnSt-D7L1 contains a tyrosine residue at position 52,
while AeD7 has phenylalanine at the equivalent position.
Consequently, AeD7 is unable to form one of the hydrogen bonds
that stabilize U46619 in the AnSt-D7L1 binding pocket and does
not bind TXA2 analogs [15]. The PGH2 analog U51605 is very
similar in structure to U46619 but lacks the v-5 hydroxyl group
and binds with approximately 10-fold lower affinity to AnSt-
D7L1, further demonstrating the importance of this functionality
in binding. The sequences of the N-terminal domains of two-
domain D7 proteins from all mosquitoes show a high degree of
Table 1. Data collection, phasing, and refinement statistics for AnSt-D7L1 and its ligand complexes.
Crystal Selenomethionine Unliganded U46619 LTC4
Resolution (A ˚) 25.0–2.00 50.0–1.77 24.0–1.45 50.0–1.43
Beamline 22-BM 22-BM 19-BM 19-BM
Wavelength (A ˚) 0.97242 0.97242 0.97910 0.97910
Completeness 99.6/95.9 99.6/96.1 99.6/95.6 99.5/96.0
Average redundancy (total/high resolution shell) 8.8/5.9 10.0/10.1 4.7/4.3 4.7/3.5
Rmerge (total/high resolution shell) 14.0/63.9 5.3/10.0 4.0/17.9 4.3/30.3
I/sigI (total/high resolution shell) 6.7/2.3 32.2/31.9 22.8/9.0 16.7/2.9
Observed reflections 200,313 331,361 250,327 262,154
Unique reflections 22,659 33,020 53,547 55,648
Space group P212121 P212121 P21 P21
Unit cell dimensions (A ˚)
a 50.405 50.445 57.932 57.968
b 56.430 56.664 40.977 40.906
c 113.759 113.920 68.416 68.387
alpha, beta, gamma (u) 90,90,90 90,90,90 90,110.70,90 90,110.68,90
Phasing statistics
Number of selenium sites 6
Contrast (SHELXE) 0.50
RMS deviations
bond lengths (A ˚) 0.027 0.007 0.007
bond angles (u) 2.03 2.18 1.11
Ramachandran plot (favored/allowed) 91.8/100 90.8/100 92.2/100
Mean B value for all atoms 16.14 11.95 13.34
Rcryst/Rfree 15.7/20.0 16.7/19.3 16.7/19.0
doi:10.1371/journal.pbio.1000547.t001
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the binding pocket that are involved with ligand binding.
Tyrosine-phenylalanine polymorphism at the equivalent of AnSt-
D7L1 position 52 is found in both anopheline and culicine D7s.
This suggests that mosquito salivary secretions contain D7 protein
forms that bind both CysLTs and TXA2, as well as forms that bind
only CysLTs, and that there may be an adaptive significance to
differences in TXA2 binding observed in AeD7 and AnSt-D7L1.
Functional Significance of AnSt-D7L1 Ligand Binding
Limitation of mast cell responses in host skin is essential for
successful blood feeding, and scavengers of small-molecule
mediators are apparently present in saliva to accomplish this task.
Immediate cutaneous reactions to mosquito bites lead to release of
histamine and LTC4, potent mediators of acute allergic processes
and inflammation [36]. Leukotrienes are produced by activated
mast cells, stimulated leukocytes, endothelial cells, and epithelial
cells through conversion of AA to 5-HPETE catalyzed by 5-
lipoxygenase [24,37,38]. The most physiologically active leukotri-
enes are LTB4 and the CysLTs. LTC4, the primary CysLT
product, is secreted by cells and converted extracellularly to LTD4
and LTE4 by successive cleavages of its glutathione moiety.
In human skin it has been demonstrated that intradermal
injection of nanomolar amounts of LTC4, LTD4, and LTE4 are
able to elicit erythema and wheal formation [36,39]. Although
CysLTs promote smooth muscle contraction [24,26] and conse-
quent vasoconstriction in other tissues such as the pulmonary
vasculature [25], they elicit a vasodilatatory response in human
skin, increasing blood flow in a manner similar to histamine
[40,41]. Moreover, CysLTs, as well as histamine, cause increased
vascular permeability and interstitial transport in the skin, favoring
edema formation [36,42].
The CysLT receptors, CysLT1 and CysLT2, are distributed in
numerous tissues. In some endothelial populations, CysLT1 is
Figure 7. Ribbon diagram of the AnSt-D7L1 structure and comparison with AeD7. Structures of AnSt-D7L1 and AeD7 have the N-terminal
domain colored blue and the C-terminal domain colored red. Cysteine residues forming disulfide bonds are shown in stick representation and colored
yellow. (A) and (B) are two views of AnSt-D7L1 related by an approximately 90u rotation around the axis shown. (C) and (D) are two views of AeD7
from Ae. aegypti oriented in the same manner as (A) and (B). The helices are labeled A–G in the N-terminal domain and A2–H2 in the C-terminal
domain. Helix B2 is missing in AnSt-D7L1, but the labeling of the other C-terminal domain helices corresponds to AeD7. The label ‘‘B2 loop’’ in (A) and
(B) indicates the portion of the structure corresponding to a-helix B2 in AeD7. The label ‘‘DS 173–301’’ marks the position of the disulfide bond linking
a-helix H2 with a-helix B2 in AeD7. The cysteine residues forming this bond are not present in AnSt-D7L1 (see panel B for comparison).
doi:10.1371/journal.pbio.1000547.g007
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and LTC4 of approximately 1 nM and 10 nM, respectively.
CysLT2 binds both LTC4 and LTD4 with an affinity of
approximately 10 nM, and both receptors bind LTE4 with
affinities near 100 nM [24]. The affinities (ranging from ,4t o
6 nM) of AnSt-D7L1 for all the three CysLTs are similar to one
another and are equal to or lower than those described for CysLT
receptors, making it likely that AnSt-D7L1 can compete with
CysLT receptors for ligands if present at sufficient concentration.
Unlike the previously described AeD7, AnSt-D7L1 also binds
TXA2 analogs, and evidence from platelet aggregation assays
strongly suggests that it binds TXA2 itself. Besides being a potent
platelet activation agonist, TXA2 induces smooth muscle contrac-
tion in vascular tissue [27], and like the CysLTs is able to cause
itching [43]. Therefore, TXA2 interferes with mosquito feeding by
promoting hemostasis (vasoconstriction and platelet aggregation),
as well as by causing inflammatory skin responses.
Mosquito bites cause injury to the skin, leading to the exposure
of collagen present in subendothelial extracellular matrix [44].
Exposed collagen interacts directly or indirectly (via VWF) with
different receptors present on the platelet surface triggering
platelet activation, aggregation, and thrombus formation. Among
these receptors is GPVI, a central collagen receptor that is able to
bind collagen both in high and low shear conditions, promoting
inside out activation of integrin receptors a2b1 and aIIbb3, thereby
increasing the affinities for their respective ligands, resulting in
Figure 8. The AnSt-D7L1 N-terminal domain ligand binding site. (A) Stereoview of the binding interactions of U46619 at the ligand binding
site. In the ligand, carbon atoms are colored blue and oxygen atoms red. Protein residues have carbon colored white, oxygen red, and nitrogen blue.
Hydrogen bonds are shown as dashed red lines. (B) Stereoview of the 2Fo-Fc electron density map covering the U46619 ligand at the AnSt-D7L1
binding site contoured at 1.0 s. In the ligand, carbon atoms are colored blue and oxygen atoms red. The ‘‘cis’’ unsaturation at position 5 and the
hydroxyl group at the v-5 position are labeled. (C) Stereoview of binding interactions of LTC4 in the AnSt-D7L1 N-terminal domain ligand binding
pocket. Since the peptide moiety of the ligand is not visible in the crystal structure, only the fatty acid portion (5(S)-hydroxy- (E,E,Z,Z)-7, 9, 11, 14-
eicosatetraenoic acid) of the molecule is shown. In the ligand, carbon atoms are shown in blue and oxygen atoms in red. Protein atoms are colored as
in (A). Hydrogen bonds are shown as red dashed lines. (D) The solvent-accessible surface of AnSt-D7L1 is colored by electrostatic potential. The N-
and C-terminal domains are labeled. Note the concentration of positive electrostatic potential surrounding the binding site for U46619 and CysLTs.
doi:10.1371/journal.pbio.1000547.g008
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containing small molecule agonists such as ADP and begin
synthesizing TXA2. These secondary mediators are able to diffuse
and activate circulating platelets that do not have contact with
collagen, resulting in potentiation of the pro-aggregatory signal
and an increase in the size of the platelet plug. Studies comparing
the effects of collagen with other GPVI agonists, such as collagen-
related peptide (CRP) [45], and platelets lacking protein Gq have
shown that ADP and TXA2 are essential for collagen-induced
platelet aggregation.
The effect of AnSt-D7L1 on collagen-induced aggregation is
similar to that obtained when platelets are treated with
indomethacin or SQ 29,548, strongly suggesting that this protein
is able to scavenge the TXA2 generated in response to collagen
exposure. Moreover, similar effects have been shown in previous
studies where platelets lacking Gaq and Ga13, G proteins coupled
to TP and to ADP receptors, were exposed to collagen [46].
Binding of TXA2 or its analogs to TP receptors on the platelet
surface activates the platelet, leading to shape change followed by
aggregation [27]. When the analog U46619 is used to promote
aggregation, the presence of AnSt-D7L1 at near equimolar
concentrations is enough to completely inhibit the platelet
aggregation response. AnSt-D7L1 also abrogates AA-induced
aggregation, strongly suggesting that it scavenges TXA2 being
produced as a result of stimulation by its biosynthetic precursor. A
recently described mutation in the human TP receptor causes
platelet dysfunction and lack of responsiveness to AA and U46619
[47] at similar doses as used in the present work and has similar
effects as those described here for AnSt-D7L1.
In order for this binding mechanism to be effective in vivo, the
protein concentration must be sufficient to remove a large fraction
of the eicosanoid ligand from the feeding site. Calvo et al. [14]
have estimated the quantities of a biogenic amine-binding protein
that is necessary to accomplish this task to be 0.03–0.3 mg per
feeding site. Mosquito salivary glands contain approximately 1–
3 mg of protein, and a mosquito injects about half of this protein
during a single feeding. Injection of 1 nmol of CysLT at a
concentration of 50 mM into a small site on the skin has been
shown to result in the appearance of large erythemas measuring
over 20 mm in diameter and persisting for many hours [36]. The
Figure 9. Detail of the C-terminal domain structure of AnSt-D7L1 and AeD7. (A) Stereoview of the region from the C-terminal domain of
AnSt-D7L1 corresponding to the biogenic amine binding site of AeD7. Carbon atoms are colored in white, oxygen in red, nitrogen in blue. Helical
segments are shown in ribbon format and hydrogen bonds are shown as dashed red lines. (B) Stereoview of the biogenic amine binding pocket
(including a bound norepinephrine molecule labeled NE) of AeD7 shown from approximately the same view as AnSt-D7L1 in panel (A). Helical
segment B2 is labeled to highlight how the conformational difference in this portion of the structure affects the positioning of residues in the ligand-
binding pocket.
doi:10.1371/journal.pbio.1000547.g009
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CysLT concentrations at the feeding site would be much lower
than this. Likewise, the data presented here indicate that a
concentration of AnSt-D7L1 of 0.03 mM is sufficient to remove a
significant fraction of the TXA2 secreted by platelets in response to
collagen stimulation and that 0.1 mM eliminates most of the
aggregation response (Figure 5). This would suggest that the TXA2
concentration in uniformly activated platelet-rich plasma is near
0.1 mM. Based on the size of a blood meal, Calvo et al. [14]
estimate the feeding volume of a mosquito to be maximally 10 mL,
and considering the relative concentration of two-domain D7
proteins in the salivary secretion of An. gambiae [48], it appears that
approximately 5–10 ng of these two-domain proteins are injected
during a single feeding period, giving a final concentration of
approximately 0.1 mM in the feeding volume.
The C-Terminal Domain and D7 Evolution
The highly expressed single-domain D7 proteins in Anopheles
species are known to bind biogenic amine ligands including
serotonin, norepinephrine, and histamine. Comparisons of these
sequences with the C-terminal domains of the two-domain D7s
from culicine species show a high degree of sequence conservation
of the residues directly involved with ligand binding (Figure 1;
[15]) The crystal structures of AeD7 (two-domain) from Ae. aegypti
and D7r4 (one-domain) from An. gambiae also show very similar
binding modes for biogenic amine ligands, with most hydrogen
bonding interactions being highly conserved between the two.
Phylogenetic analyses of D7 sequences suggest that the two-
domain forms are ancestral and that the single domain proteins
found in both culicine and anopheline mosquitoes are derived
from an apparent duplication of the C-terminal domain of a two-
domain D7 protein [14]. In culicine mosquitoes, the function of
the single-domain proteins is not known, but a lack of conservation
of residues involved with biogenic amine binding suggests that
biogenic amines are not the target ligand [16].
Sequence comparisons of apparently orthologous two-domain
D7s from culicine and anopheline species initially suggested that
the C-terminal domain of the anopheline proteins lack some
important determinants of biogenic amine binding, while
maintaining a high overall degree of similarity with the culicine
forms. The work presented here shows that the biogenic amine
binding function has indeed been lost in the anopheline proteins
and that the loss of function is due to rearrangements that
dramatically affect the structure of the binding pocket. The loss of
a-helix B2 that is found in both AeD7 and D7r results in Arg 177
taking on a different conformation in AnSt-D7L1. Along with the
bulky side chain of Trp 173, Arg 177 fills most of what would be
the biogenic amine binding pocket in the D7 forms that bind these
ligands (Figure 9A,B). Two crystal forms of AnSt-D7L1 are
described in this study. The orthorhombic form is obtained in the
absence of eicosanoid ligands, while the monoclinic form is
obtained in their presence. In the two forms, the structure of the
C-terminal domain binding pocket region is nearly identical
(Figure S4), indicating that interactions in the crystal play no role
in producing these differences between AnSt-D7L1 and AeD7.
It appears that the cluster of single-domain D7 proteins in
anopheline mosquitoes has taken over the function of the C-
terminal domain of the two-domain D7s of culicine (Aedes and
Culex) mosquitoes, making it unnecessary for AnSt-D7L1 and
other anopheline forms to maintain the biogenic amine-binding
function. Apparently, another function has been acquired by the
C-terminal domain of these proteins that may be entirely
unrelated to the binding of small-molecule ligands. This case
seems to be an example of extensive duplication of salivary protein
genes allowing structural and functional diversification within
protein families. The D7 protein family represents a case where a
duplication of one domain of an ancestral two-domain protein to
form a one-domain form has allowed the ancestral protein to lose
its original function and almost certainly acquire a new one. We
are currently working to determine the more recently acquired
function of the C-terminal domain in this group of proteins.
Materials and Methods
Materials
UltraPure guanidinium hydrochloride was obtained from
Invitrogen. L-arginine, serotonin, norepinephrine, histamine,
ADP, PMA, and indomethacin were obtained from Sigma-
Aldrich. All leukotrienes and prostaglandins as well as U46619,
carboxyclic TXA2, TXB2, U51605, AA (for ITC experiment),
PAF, and SQ 29,548 were obtained from Cayman Chemical.
Native collagen fibrils (type I) from equine tendons, AA, and
ristocetin used in platelet experiments were purchased from
Chrono-Log Corporation. Convulxin and RPAI1 were prepared
as described previously [22,49].
Protein Expression, Refolding, and Purification
The AnSt-D7L1 cDNA, minus its signal sequence, was cloned
into the expression vector pET17b and was expressed in
BL21(DE3)pLysS cells grown for 3 h after induction with 1 mM
IPTG [50]. After expression, inclusion bodies were washed in
Triton X-100 as previously reported [50] and denatured in
100 mL of 6 M guanidinium HCl and 20 mM Tris-HCl pH 8.0
containing 10 mM DTT. This solution (50 mL) was refolded by
adding dropwise to 4 L of 0.3 M L-arginine in 50 mM CAPS
buffer pH 10.0. The solution was stirred for 1 h at 25uC and
transferred to 4uC overnight. The protein was concentrated and
purified by gel filtration chromatography on Sephacryl S-100,
followed by anion exchange chromatography on SP sepharose.
The protein was further purified by a final step of gel filtration
chromatography on Superdex 75. Purity was assessed by SDS-
PAGE (Figure S5).
Isothermal Titration Calorimetry (ITC)
AnSt-D7L1 was prepared for ITC experiments by dialysis
against 20 mM Tris-HCl 0.15 M NaCl pH 7.4 for 1 h. Binding
experiments were performed on a MicroCal VP-ITC instrument.
Aliquots of lipid stock solutions in ethanol or methyl acetate were
dried under a stream of nitrogen in a glass vial, then dissolved in
20 mM Tris HCl, 0.15 M NaCl pH 7.4, vortexed, and sonicated
for 8 min. Non-lipidic ligands were dissolved in 20 mM Tris HCl,
0.15 M NaCl pH 7.4. All solutions were degassed prior to use.
Assays were performed at 35uC with successive 10 mL injections,
with a spacing interval of 180 s and a syringe stirring speed of
290 rpm. In all the cases, after subtraction of the heats of dilution,
the measured heats were converted to enthalpies and analyzed by
fitting to a single-site binding model using the Microcal Origin
software.
Smooth Muscle Bioassays
Guinea pig ileum contraction in response to LTC4 was
measured isotonically with an initial load of 1.0 g tension, and
rat aorta ring contraction in response to U46619 was measured
isometrically after a distension of 2.5 g. Tissue preparations were
bathed in modified Tyrode solution (with 10 mM HEPES buffer,
pH 7.4) during the course of the experiment, and the solutions
were kept oxygenated by bubbling air into the bath [51].
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Platelets were prepared as described previously [52]. Human
platelet-rich plasma (,2610
5/mL final density) and Tyrode-BSA
buffer [52] in the presence or absence of AnSt-D7L1 (final volume
300 mL) were placed in an aggregometer [52] and stirred at
1,200 rpm at 37uC for 1 min prior to the addition of different
agonists. In experiments using the human TP (TXA2 receptor)
antagonist SQ 29,548 or made in the presence of proteins (AnSt-
D7L1 or RPAI-1), those compounds were added to the platelet
suspension and Tyrode mix prior to addition of agonists. In
experiments in which indomethacin, a general cycloxygenase
inhibitor, was used, platelets were pre-incubated with the
compound for 5 min prior to addition of agonists.
Crystallization and Data Collection
AnSt-D7L1 was crystallized using the hanging drop vapor
diffusion method from 0.1 M Tris pH 8.5, 0.2 M lithium sulfate,
30% PEG 3000. The crystals were frozen for data collection in the
crystallization buffer described above, containing 10% glycerol.
To prepare a selenomethionine derivative of AnSt-D7L1, the
expression plasmid construct was transformed into BL834(DE3)-
pLysS cells and grown in SelenoMet media (Molecular Dimen-
sions Ltd.) as per the manufacturer’s instructions. In order to
obtain crystals with the protein bound to its ligands, either LTC4
or U46619 prepared in 10 mM Tris-HCl pH 8.0 buffer was pre-
incubated with AnSt-D7L1 for 10 min but in a 1.3 molar excess
when compared to the protein concentration. Prior to data
collection, the crystals were frozen using the cryoprotectant
described above.
Data collection was performed at beamlines 22-BM at the
Southeast Regional Collaborative Access Team (SER-CAT) and
19-BM of the Structural Biology Center (SBC), Advanced Photon
Source (APS), Argonne National Laboratory. Crystals of the
ligand-free form of the protein belong to the space group P212121
and contain one monomer per asymmetric unit (Table 1). Crystals
of the LTC4 and U46619 complexes belong to the space group
P21 and also contain one monomer per asymmetric unit. Four
data sets were collected from a ligand-free selenomethionine
crystal (2.00 A ˚ resolution), a ligand-free crystal (1.77 A ˚ resolution),
a U46619-complexed co-crystal (1.45 A ˚ resolution), and a LTC4-
complexed co-crystal (1.43 A ˚ resolution).
Structure Solution and Refinement
The structure of AnSt-D7L1 was determined using a combina-
tion of single wavelength anomalous dispersion (SAD) methods
with data collected at the selenium absorption edge, and molecular
replacement using the N-terminal domain of AeD7 from Ae. aegypti
as the search model (Table 1) [15]. The data were indexed,
integrated, and scaled using HKL2000 or HKL3000 [53]. Initial
phases were obtained from the selenium data using SHELX-C, D,
and E [54,55]. After molecular replacement using PHASER [56]
with the selenomethionine data set, a model of the N-terminal
domain of AnSt-D7L1 was refined using REFMAC [57] including
the phase information from the SAD experiment. After this
procedure, electron density for some of the helical segments in the
C-terminal domain could be observed, allowing manual building
of this portion of the model in Coot [58]. The complete model was
refined using REFMAC [57], with a TLS model being applied in
the later stages utilizing a single TLS group [57]. The structures of
the ligand complexes were determined by molecular replacement
using PHASER, with the ligand-free protein as a search model
[59]. The structures were rebuilt using Coot and refined using
REFMAC. Since little electron density was observed for the
peptidyl portion of LTC4, the ligand was modeled as only its lipid
portion, 5(S)-hydroxy-(E,E,Z,Z)-7,9,11,14-eicosatetraenoic acid.
The structures of ligand-free AnSt-D7L1 (3NGV), its U46619
complex (3NHT), and its LTC4 complex (3NHI) have been
deposited with the RCSB protein data bank.
Supporting Information
Figure S1 Structures of leukotrienes and thromboxanes
and thromboxane analogs. (A) LTC4, (B) LTD4, (C) LTE4,
(D) TXA2, (E) carbocyclic TXA2, (F) U46619, (G) U51605.
Found at: doi:10.1371/journal.pbio.1000547.s001 (1.67 MB TIF)
Figure S2 Gel filtration of the AnSt-D7L1-LTC4 complex
(A) and free LTC4 (B) on a Superdex peptide column. (A)
AnSt-D7L1 (100 mL) 10 mM and LTC4 10 mM were incubated
together to form a complex which was then injected onto the
column. (B) LTC4 was injected alone in order to obtain a retention
volume measurement for the free ligand. In both cases, the column
was eluted with 100 mM ammonium acetate pH 7.2 at a flow rate
of 60 mL per min.
Found at: doi:10.1371/journal.pbio.1000547.s002 (0.39 MB TIF)
Figure S3 Mass spectral analysis of the AnSt-D7L1-
LTC4 complex after gel filtration chromatography. Top:
The peak fraction from the gel filtration of Figure S2 (3 ml) was
applied to a C18 column and eluted with 5% methanol 0.1%
acetic acid for 10 min, then 5%–95% methanol 0.1% acetic acid
(0.3 mm diameter column in 20 min at 3 ml/min). The eluent was
analyzed directly by MS/MS. Bottom is the same analysis applied
to 1 mlo f1 0mM LTC4 solution. The chromatograms represent
abundance of the m/z 626.7 molecular ion (M+H) of LTC4. The
inset is a sample collision-induced dissociation spectrum (35%
intensity) recorded at 61–65 min.
Found at: doi:10.1371/journal.pbio.1000547.s003 (2.15 MB TIF)
Figure S4 Structural comparisons of D7 proteins. (A)
Stereoview of superposed carbon alpha traces of the C-terminal
domains of AnSt-D7L1 (red) and AeD7 (black). Helix B2 of AeD7
and H2 from both proteins are labeled in the appropriate colors. (B)
StereoviewofsuperposedN-terminaldomainsfromligand-freeAnSt-
D7L1 and its U46619 complex. The N-termini are labeled. (C)
Stereoview of superposed C-terminal domains from ligand-free AnSt-
D7L1 and its U46619 complex. The difference in position of the C-
terminus for each protein is indicated in the appropriate color.
Found at: doi:10.1371/journal.pbio.1000547.s004 (2.52 MB TIF)
Figure S5 Purification of recombinant AnSt-D7L1. (A)
Gel filtration chromatography of purified AnSt-D7L1 on Super-
dex 75. Elution buffer: 20 mM Tris HCl pH 8.0, 0.15 M NaCl.
(B) SDS-PAGE gel of purified recombinant AnSt-D7L1 stained
with Coomassie blue.
Found at: doi:10.1371/journal.pbio.1000547.s005 (5.20 MB TIF)
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